Mouse ER+/PIK3CAH1047R breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents.
Mouse ER+/PIK3CAH1047R breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents.
复制标题
由外源雌激素引起的小鼠 ER /PIK3CAH1047R 乳腺癌对雌激素具有异质依赖性,并在 BH3 和 PI3K 药物的作用下经历 BIM 依赖性细胞凋亡。
DOI:
10.1038/s41388-018-0436-4
复制
发表时间:
2019
期刊:
影响因子:
8
通讯作者:
Parsons,Ramon
中科院分区:
文献类型:
--
作者:
Stratikopoulos,EliasE;Kiess,Nicole;Szabolcs,Matthias;Pegno,Sarah;Kakit,Cheung;Wu,Xuewei;Poulikakos,PoulikosI;Cheung,Pamela;Schmidt,Hank;Parsons,Ramon
Estrogen dependence is major driver of ER + breast cancer, which is associated with PI3K mutation. PI3K inhibition (PI3Ki) can restore dependence on ER signaling for some hormone therapy-resistant ER + breast cancers, but is ineffective in others. Here we show that short-term supplementation with estrogen strongly enhancedPik3caH1047R−induced mammary tumorigenesis in mice that resulted exclusively in ER + tumors, demonstrating the cooperation of the hormone and the oncogene in tumor development. Similar to human ER + breast cancers that are endocrine-dependent or endocrine-independent at diagnosis, tumor lines from this model retained ER expression but were sensitive or resistant to hormonal therapies. PI3Ki did not induce cell death but did cause upregulation of the pro-apoptotic gene BIM. BH3 mimetics or PI3Ki were unable to restore hormone sensitivity in several resistant mouse and human tumor lines. Importantly however, combination of PI3Ki and BH3 mimetics had a profound, BIM-dependent cytotoxic effect in PIK3CA-mutant cancer cells while sparing normal cells. We propose that addition of BH3 mimetics offers a therapeutic strategy to markedly improve the cytotoxic activity of PI3Ki in hormonal therapy-resistant and ER−independent PIK3CA-mutant breast cancer.
影响因子:
--
作者:
K. Aktories
通讯作者:
K. Aktories